Step 6: No Refunds, No Support Attempts to contact the vendor usually fail
At a White House event Thursday, President Trump announced deals with drugmakers Novo Nordisk and Eli Lilly to offer their popular GLP-1 obesity and diabetes drugs at lower prices for some Americans, namely some on Medicare and Medicaid plans
By Wendy Galyen, LCSW, BC-TMHOwner of Thrive for Life Counseling LLC
Semaglutide, kidney health, and the bigger urinary picture Understanding UTI risk in the context of semaglutide requires a broader look at how the medication affects the urinary system overall
Most of the evidence comes from standard-dose studies in metabolic populations, case reports, observational data, and clinical observations from practitioners
Key Takeaways GLP-1s can help with weight and blood sugar , and early research hints at possible mood effects but they arent approved for psychiatric use